Leukemia Research
Volume 33, Issue 11 , Pages 1463-1468 , November 2009

High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort

  • M.D. Seftel

      Affiliations

    • Section of Haematology/Oncology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
    • Corresponding Author InformationCorresponding author at: Department of Medical Oncology and Haematology, CancerCare Manitoba, ON 2081, 675 Mcdermot Avenue, Winnipeg, MB, R3E0V9, Canada. Tel.: +1 204 787 3594; fax: +1 204 786 0196.
    • ,
  • A.A. Demers

      Affiliations

    • Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
    • Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Manitoba, Canada
    • ,
  • V. Banerji

      Affiliations

    • Section of Haematology/Oncology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
    • ,
  • S.B. Gibson

      Affiliations

    • Manitoba Institute for Cell Biology, Winnipeg, Manitoba, Canada
    • ,
  • C. Morales

      Affiliations

    • Department of Pathology, University of Manitoba, Winnipeg, Manitoba, Canada
    • ,
  • G. Musto

      Affiliations

    • Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Manitoba, Canada
    • ,
  • M.W. Pitz

      Affiliations

    • Section of Haematology/Oncology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
    • ,
  • J.B. Johnston

      Affiliations

    • Section of Haematology/Oncology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
    • Manitoba Institute for Cell Biology, Winnipeg, Manitoba, Canada

Received 20 April 2009 ,Revised 9 June 2009 ,Accepted 11 June 2009.

References 

  1. Matasar MJ, Ritchie EK, Consedine N, Magai C, Neugut AI. Incidence rates of the major leukemia subtypes among US hispanics, blacks, and non-hispanic whites. Leuk Lymphoma. 2006;47:2365–2370
  2. Eichhorst B, Hallek M. Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL). Best Pract Res Clin Haematol. 2007;20:469–477
  3. Müller-Hermelink HK, Montserrat E, Catovsky D, Campo E, Harris NL, Stein H, et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma. In:  Swerdlow SH,  Campo E,  Harris NL editor. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC; 2008;p. 180–182
  4. Dores GM, Anderson WF, Curtis RE, et al. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol. 2007;139:809–819
  5. Public Health Agency of Canada. Cancer Surveillance Online. Available from URL: http://dsol-smed.phac-aspc.gc.ca/dsol-smed/cancer/index_e.html; 2009 [accessed 21.03.09].
  6. Alexander F, Ricketts TJ, Mckinney PA, Cartwright RA. Cancer registration of leukaemias and lymphomas: results of a comparison with a specialist registry. Community Med. 1989;11(2):81–89
  7. Turesson I, Linet MS, Bjorkholm M, et al. Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964–2003. Int J Cancer. 2007;
  8. Zent CS, Kyasa MJ, Evans R, Schichman SA. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer. 2001;92:1325–1330
  9. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990–4997
  10. Dronca RS, Hanson CA, Jevremovic D, et al. CD5+ chronic B-cell lymphoproliferative disorders could contain a novel disease entity. Blood. 2008;112:2065;[abstract]
  11. Statistics Canada. 2006 Census. Available from URL: http://www12.statcan.ca/english/census06/data/popdwell/Table.cfm?T=101; 2009 [accessed 21.03.09].
  12. Mauro FR, Foa R, Giannarelli D, et al. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood. 1999;94:448–454
  13. Catovsky D, Fooks J, Richards S. Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC working party on leukaemia in adults. Br J Haematol. 1989;72:141–149
  14. Muller-Hermelink HK, Catovsky D, Montserrat E, Harris NL. Chronic lymphocytic leukemia/small lymphocytic lymphoma. In:  Jaffe ES,  Harris NL,  Stein H,  Vardiman JW editor. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001;p. 127–130
  15. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101–121
  16. Henson DE, Ries LA. The relative survival rate. Cancer. 1995;76:1687–1688
  17. Mulligan CS, Thomas ME, Mulligan SP. Monoclonal B-lymphocytosis: analysis of the incidence, demographics. Nature and subclassification in 414 patients. Blood. 2008;112:3129;[abstract]
  18. Caporaso N, Goldin L, Plass C, et al. Chronic lymphocytic leukaemia genetics overview. Br J Haematol. 2007;139:630–634
  19. Carreon JD, Morton LM, Devesa SS, et al. Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996–2004. Cancer Causes Control. 2008;19:1171–1181
  20. Pang JWY, Cook LS, Schwartz SM, Weiss NS. Incidence of leukemia in Asian migrants to the United States and their descendants. Cancer Causes Control. 2002;13:791–795
  21. Statistics Canada. Selected Ethnic Origins for Canada, Provinces and Territories. Available from URL: http://www12.statcan.ca/english/census01/products/highlight/ETO/Table1.cfm?Lang=E&T=501&GV=1&GID=46; 2009 [accessed 21.03.09].
  22. National Cancer Institute. Number of Persons by Race and Hispanic Ethnicity for SEER Participants (2000 Census Data). Available from URL: http://seer.cancer.gov/registries/data.html; 2009 [accessed 21.03.09].
  23. Gale RP, Cozen W, Goodman MT, Wang FF, Bernstein L. Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles county. Leuk Res. 2000;24:665–669
  24. Herrinton LJ, Goldoft M, Schwartz SM, Weiss NS. The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants. Cancer Causes Control. 1996;7:224–230
  25. Yanagihara ET, Blaisdell RK, Hayashi T, Lukes RJ. Malignant lymphoma in Hawaii-Japanese: a retrospective morphologic survey. Hematol Oncol. 1989;7:219–232
  26. Apelgren P, Hasselblom S, Werlenius O, Nilsson-Ehle H, Andersson PO Western Sweden Lymphoma Group. Evaluation of clinical staging in chronic lymphocytic leukemia- population-based study. Leuk Lymphoma. 2006;47:2505–2516
  27. Brenner H, Gondos A, Pulte D. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood. 2008;111:4916–4921
  28. Zippin C, Cutler SJ, Reeves WJ, Lum D. Survival in chronic lymphocytic leukemia. Blood. 1973;42:367–376
  29. Molica S. Sex differences in incidence and outcome of chronic lymphocytic leukemia patients. Leuk Lymphoma. 2006;47:1477–1480
  30. Catovsky D, Matutes E, Morilla A, et al. Gender as a prognostic factor in CLL. Biological pointers to the improved outcome of women. Blood. 2004;104:957
  31. Walewska R, Majid A, Davis Z, et al. Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1-69. Leukemia. 2007;21:2537–2538

PII: S0145-2126(09)00291-4

doi: 10.1016/j.leukres.2009.06.013

Leukemia Research
Volume 33, Issue 11 , Pages 1463-1468 , November 2009

Article Tools

* Image Usage & Resolution